Benzinga's top rating upgrades has VYGR @ outperform.
Second quarter earnings of $.80 compared to year ago quarter.
Check out latest news about association with MEREK !
This is a great ''Long Term'' hold, IMHO.
(1)
(0)
Voyager Therapeutics Inc. (VYGR) Stock Research Links